These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7971707)

  • 21. The effect of sodium lauryl sulphate, cetrimide and polysorbate 20 surfactants on complex coacervate volume and droplet size.
    Duquemin SJ; Nixon JR
    J Pharm Pharmacol; 1985 Oct; 37(10):698-702. PubMed ID: 2867137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Felodipine β-cyclodextrin complex as an active core for time delayed chronotherapeutic treatment of hypertension.
    Pagar KP; Vavia PR
    Acta Pharm; 2012 Nov; 62(3):395-410. PubMed ID: 23470351
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Xylitol as a potential co-crystal co-former for enhancing dissolution rate of felodipine: preparation and evaluation of sublingual tablets.
    Arafa MF; El-Gizawy SA; Osman MA; El Maghraby GM
    Pharm Dev Technol; 2018 Jun; 23(5):454-463. PubMed ID: 27681386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of the intragastric location of extended release tablets on food interactions.
    Weitschies W; Wedemeyer RS; Kosch O; Fach K; Nagel S; Söderlind E; Trahms L; Abrahamsson B; Mönnikes H
    J Control Release; 2005 Nov; 108(2-3):375-85. PubMed ID: 16213057
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential effects of detergents on keratinocyte gene expression.
    van Ruissen F; Le M; Carroll JM; van der Valk PG; Schalkwijk J
    J Invest Dermatol; 1998 Apr; 110(4):358-63. PubMed ID: 9540975
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Investigation of prandial effects on hydrophilic matrix tablets.
    Abrahamsson B; Roos K; Sjögren J
    Drug Dev Ind Pharm; 1999 Jun; 25(6):765-71. PubMed ID: 10349562
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design and pharmacokinetics of Logimax, a new extended-release combination tablet of felodipine and metoprolol.
    Abrahamsson B; Edgar B; Lidman K; Wingstrand K
    Blood Press Suppl; 1993; 1():10-5. PubMed ID: 8173686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of micelles on the spectral characteristics of the prototropic species of 2-(2'-aminophenyl)benzimidazole.
    Santra S; Dogra SK
    Spectrochim Acta A Mol Biomol Spectrosc; 2000 Apr; 56(5):915-25. PubMed ID: 10809067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fractal structure determines controlled release kinetics of monolithic osmotic pump tablets.
    Yin X; Li H; Liu R; Chen J; Ji J; Chen J; Shao Q; Xiao T; York P; He Y; Zhang J
    J Pharm Pharmacol; 2013 Jul; 65(7):953-9. PubMed ID: 23738722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preparation of a push-pull osmotic pump of felodipine solubilized by mesoporous silica nanoparticles with a core-shell structure.
    Wu C; Zhao Z; Zhao Y; Hao Y; Liu Y; Liu C
    Int J Pharm; 2014 Nov; 475(1-2):298-305. PubMed ID: 25148731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Application of biorelevant saliva-based dissolution for optimisation of orally disintegrating formulations of felodipine.
    Ali J; Zgair A; Hameed GS; Garnett MC; Roberts CJ; Burley JC; Gershkovich P
    Int J Pharm; 2019 Jan; 555():228-236. PubMed ID: 30465852
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased dissolution and physical stability of micronized nifedipine particles encapsulated with a biocompatible polymer and surfactants in a wet ball milling process.
    Li N; DeGennaro MD; Liebenberg W; Tiedt LR; Zahr AS; Pishko MV; de Villiers MM
    Pharmazie; 2006 Jul; 61(7):595-603. PubMed ID: 16889066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bioequivalence, pharmacokinetic and pharmacodynamic response to combined extended release formulations of felodipine and metoprolol in healthy volunteers.
    Aberg J; Abrahamsson B; Grind M; Nyberg G; Olofsson B
    Eur J Clin Pharmacol; 1997; 52(6):471-7. PubMed ID: 9342583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Twenty-four hour blood pressure profiles in hypertensive patients following various formulations and dosage regimens of felodipine.
    Blychert E; Frisén M; Karlsson O; Rydén L
    Eur J Clin Pharmacol; 1992; 42(1):25-30. PubMed ID: 1541312
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the mechanism of skin enhancing surfactants on the biomembrane of shed snake skin.
    Wonglertnirant N; Ngawhirunpat T; Kumpugdee-Vollrath M
    Biol Pharm Bull; 2012; 35(4):523-31. PubMed ID: 22466556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of surfactants on the solubility and dissolution profiles of a poorly water-soluble basic drug, carvedilol.
    Incecayir T
    Pharmazie; 2015 Dec; 70(12):784-90. PubMed ID: 26817275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Felodipine extended-release tablets once daily are equivalent to plain tablets twice daily in treating hypertension. Dutch Hospital Multicentre Group.
    Hart W; Westberg B
    J Cardiovasc Pharmacol; 1990; 15 Suppl 4():S65-9. PubMed ID: 1693733
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toxicity of Different Types of Surfactants via Cellular and Enzymatic Assay Systems.
    Sutormin OS; Kolosova EM; Torgashina IG; Kratasyuk VA; Kudryasheva NS; Kinstler JS; Stom DI
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613956
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterisation of fenofibrate dissolution delivered by a self-microemulsifying drug-delivery system.
    Wei JD; Ho HO; Chen CH; Ke WT; Chen ET; Sheu MT
    J Pharm Pharmacol; 2010 Dec; 62(12):1685-96. PubMed ID: 21054394
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Efficacy, safety and tolerance of Felodipine controlled release tablets and Felodipine controlled release tablets associated combination therapy in the treatment of mild to moderate essential hypertension in China].
    Chen YY; Sun NL; Zhang WZ; Wu HY; Zhang L; Yu ZQ; Zhang FC; Xiang XP; Liu HL; Shen FR; Tao J; Zhao JA
    Beijing Da Xue Xue Bao Yi Xue Ban; 2007 Dec; 39(6):619-23. PubMed ID: 18087554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.